Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bindarit + irbesartan versus irbesartan alone for albuminuria in diabetic nephropathy
2006-006191-38Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bindarit and irbesartan in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Angelini Pharma. Started Mar 2007; status: completed.
02
Drugs
bindaritirbesartan
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-006191-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006191-38.